Contact transscleral ciliary body photodynamic therapy in pigmented rabbits using verteporfin and diode laser: evaluation of treatment parameters
- PMID: 16877266
- DOI: 10.1080/02713680600788189
Contact transscleral ciliary body photodynamic therapy in pigmented rabbits using verteporfin and diode laser: evaluation of treatment parameters
Abstract
Purpose: To evaluate the treatment parameters necessary for achieving ciliary body photodynamic damage, enough to significantly reduce IOP, using verteporfin and a diode laser.
Design: Animal study.
Methods: The right eye ciliary body of 30 pigmented rabbits was irradiated using verteporfin (Visudyne) and a diode laser. Photosensitizer dose ranged from 0.375 to 2 mg/kg. Three adjacent laser spots were applied 0.5 mm behind limbus at 12 o'clock position using a contact transscleral technique. The laser power was ranging from 10 to 70 mW and the duration of irradiation from 1 to 5 min per spot. The left eyes of the rabbits were used as controls. Animals were sacrificed 24 hours after the procedure and their eyes were evaluated by means of light and electron microscopy. A step-by-step approach was adopted with adjustment of experimental parameters according to histological findings. The end point was to identify the irradiation parameters necessary for induction of photodynamic damage while minimizing thermal damage. Subsequently, 10 more animals were used in order to verify the effectiveness of these irradiation parameters in reducing the intraocular pressure.
Results: The therapy parameters that led to photodynamic effect avoiding thermal damage were laser power of 25 mW, irradiation time of 3 min per spot, and verteporfin dose of 1 mg/kg. Transscleral ciliary body irradiation using these parameters resulted in vascular thrombosis of ciliary vessels and in substantial edema, resulting in separation of the two ciliary epithelium layers. These parameters were applied to 4 rabbits, resulting in a mean IOP reduction of 1.8 mmHg +/- 1.2 that lasted for 4 days. An increase of the laser power to 35 mW tested in 6 additional animals, resulted in mean IOP reduction of 2.2 mmHg +/- 1.2, lasting 6 days; some minimal thermal damage was seen with the later settings.
Conclusion: The combination of verteporfin and 690 nm diode laser is effective for the induction of ciliary body photodynamic damage, which results in significant but temporary IOP reduction, after transscleral PDT in pigmented rabbits. With appropriate parameter selection, intraocular pressure reduction can be achieved while thermal damage is kept to a minimum.
Similar articles
-
Transscleral ciliary body photodynamic therapy using phthalocyanine and a diode laser: functional and morphologic implications in albino rabbits.Ophthalmic Surg Lasers. 1997 Jun;28(6):483-94. Ophthalmic Surg Lasers. 1997. PMID: 9189952
-
Ciliary body PDT in pigmented rabbit eyes: effect of single and repeated treatment.Curr Eye Res. 2000 Jun;20(6):469-79. Curr Eye Res. 2000. PMID: 10980659
-
Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2498-507. doi: 10.1167/iovs.05-0959. Invest Ophthalmol Vis Sci. 2006. PMID: 16723462
-
Development and optimization of a diode laser for photodynamic therapy.Laser Ther. 2011;20(3):195-203. doi: 10.5978/islsm.20.195. Laser Ther. 2011. PMID: 24155529 Free PMC article. Review.
-
Micropulse Transscleral Cyclophotocoagulation: A Hypothesis for the Ideal Parameters.Med Hypothesis Discov Innov Ophthalmol. 2018 Fall;7(3):94-100. Med Hypothesis Discov Innov Ophthalmol. 2018. PMID: 30386797 Free PMC article. Review.
Cited by
-
Retinopathy of prematurity and neonatal gut microbiome: An interview with Professor Dimitra Skondra, Associate Professor of Ophthalmology and Vitreoretinal Surgeon at The University of Chicago (USA).Exp Ther Med. 2020 Dec;20(6):294. doi: 10.3892/etm.2020.9424. Epub 2020 Oct 30. Exp Ther Med. 2020. PMID: 33209138 Free PMC article.
-
Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo.Nanomedicine (Lond). 2011 Apr;6(3):475-87. doi: 10.2217/nnm.11.8. Nanomedicine (Lond). 2011. PMID: 21542686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources